Akaza Research announces it will present OpenClinica, the leading open source clinical trials software platform, at the upcoming Cancer Biomedical Informatics Grid (caBIG) annual meeting February 5-7.
CAMBRIDGE, MA (PRWeb) January 6, 2007 -- Akaza Research will exhibit the OpenClinica™ clinical trials platform at the caBIG annual meeting, February 5-7 in Washington, DC. caBIG (cancer Biomedical Informatics Grid) is an initiative within the National Cancer Institute to create a network of interoperable informatics tools for cancer research that speeds the delivery of innovative approaches to the prevention and treatment of cancer.
"We are excited to present OpenClinica™ at the caBIG annual meeting. caBIG represents a positive paradigm shift in clinical informatics and Akaza Research is proud to support its continued growth and success, " said Ben Baumann, Akaza's VP of Business Development.
Akaza Research has taken substantial steps to make the popular open source clinical trials platform, OpenClinica™, highly compatible with the caBIG infrastructure. "OpenClinica's targeted compatibility with caBIG means that cancer researchers can obtain a much higher degree of producitivty from their research efforts," added Baumann.
About Akaza Research
Akaza Research, a leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data collection and management software platform. Akaza brings Open Source Software solutions into the mainstream of the clinical research enterprise by making high quality, standards-based systems accessible for private and public research. Akaza Research provides support, training, and consulting services to its customers worldwide. See www.akazaresearch.com.
About OpenClinica
OpenClinica™ is an open source web-based software platform that enables sponsors and investigators to manage clinical research data in multi-site studies. It facilitates protocol configuration, design of case report forms, electronic data capture, and study/data management.
OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a strictly standards-based, extensible, and modular platform. OpenClinica v2.0 was released in November 2006 under the GNU Lesser General Public License (LGPL). See www.OpenClinica.org.
###
|
